The power of the Risk of Ovarian Malignancy Algorithm considering menopausal status: a comparison with CA 125 and HE4.

CONCLUSION: The discrimination power of tumor markers for ovarian cancer was different according to menopausal status. In predicting ovarian malignancy, ROMA was neither superior to HE4 in premenopausal women nor superior to CA 125 in postmenopausal women. PMID: 31576682 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/31576682?dopt=Abstract

Source: Journal of Gynecologic Oncology - October 4, 2019 Category: OBGYN Tags: J Gynecol Oncol Source Type: research